Eagle’s Eye View: What Are the Effects of 1- vs. 3-Month DAPT?

Oct 18, 2023   |  Kim A. Eagle, MD, MACC

Podcast
Print
Font Size
A
A
A

In this week’s View, Dr. Eagle explores the role of one- or three-month DAPT in HBR patients with or without oral anticoagulant therapy after PCI. He then discusses a meta-analysis of the co-administration of mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure. Finally, Dr. Eagle examines the use of PET imaging in following patients with giant cell arteritis.

Twitter Links:

Clinical Topics: Anticoagulation Management, Cardiac Surgery, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Vascular Medicine, Aortic Surgery, Cardiac Surgery and Heart Failure, Acute Heart Failure, Interventions and Imaging, Interventions and Vascular Medicine, Computed Tomography, Nuclear Imaging

Keywords: Anticoagulants, Hemorrhage, Myocardial Ischemia, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Diabetes Mellitus, Type 2, Heart Failure, Sodium-Glucose Transporter 2 Inhibitors, Aortic Aneurysm, Fluorodeoxyglucose F18, Giant Cell Arteritis, Positron-Emission Tomography, Vascular Diseases, EaglesEyeView


< Back to Listings